Clinical trial
Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and…
NCT00004464 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other · Completed
Key facts
| NCT number | NCT00004464 |
|---|---|
| Title | Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria |
| Official title | High Dose Cyclophosphamide for the Treatment of Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria |
| Lead sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Aplastic Anemia, Paroxysmal Hemoglobinuria, Nocturnal |
| Intervention type | Drug |
| Interventions | cyclophosphamide, filgrastim |
| Enrollment | 69 |
| Start date | Feb 1, 1996 |
| Primary completion | Mar 1, 2007 |
| Completion | Nov 11, 2008 |
| First posted | Oct 19, 1999 |
| Last update posted | Jan 18, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: